Chrome Extension
WeChat Mini Program
Use on ChatGLM

Serum Erythropoietin as Prognostic Marker in Myelodysplastic Syndromes

Acta medica portuguesa(2015)

Cited 6|Views20
No score
Abstract
This study suggests that increased erythropoietin levels at diagnosis can by itself be a poor prognosis factor inmyelodysplastic syndromes patients, with higher values in patients with progression to acute leukaemia and decreased overall survival.
More
Translated text
Key words
Erythropoietin,Myelodysplastic Syndromes,Prognosis
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined